162 related articles for article (PubMed ID: 22945693)
1. Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression.
Galrão AL; Sodré AK; Camargo RY; Friguglietti CU; Kulcsar MA; Lima EU; Medeiros-Neto G; Rubio IG
Endocrine; 2013 Feb; 43(1):225-9. PubMed ID: 22945693
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors.
Galrão AL; Camargo RY; Friguglietti CU; Moraes L; Cerutti JM; Serrano-Nascimento C; Suzuki MF; Medeiros-Neto G; Rubio IG
J Clin Endocrinol Metab; 2014 Jun; 99(6):E944-52. PubMed ID: 24432988
[TBL] [Abstract][Full Text] [Related]
4. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
[TBL] [Abstract][Full Text] [Related]
5. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
[TBL] [Abstract][Full Text] [Related]
6. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
7. Sodium iodide symporter and pendrin expression in human thyroid tissues.
Mian C; Lacroix L; Alzieu L; Nocera M; Talbot M; Bidart JM; Schlumberger M; Caillou B
Thyroid; 2001 Sep; 11(9):825-30. PubMed ID: 11575851
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells.
Passon N; Puppin C; Lavarone E; Bregant E; Franzoni A; Hershman JM; Fenton MS; D'Agostino M; Durante C; Russo D; Filetti S; Damante G
Thyroid; 2012 May; 22(5):487-93. PubMed ID: 22510021
[TBL] [Abstract][Full Text] [Related]
9. B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1.
Choi YW; Kim HJ; Kim YH; Park SH; Chwae YJ; Lee J; Soh EY; Kim JH; Park TJ
Exp Mol Med; 2014 Nov; 46(11):e120. PubMed ID: 25378232
[TBL] [Abstract][Full Text] [Related]
10. The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.
Lavarone E; Puppin C; Passon N; Filetti S; Russo D; Damante G
Mol Cell Endocrinol; 2013 Jan; 365(1):1-10. PubMed ID: 22982218
[TBL] [Abstract][Full Text] [Related]
11. Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours.
Luciani P; Buci L; Conforti B; Tonacchera M; Agretti P; Elisei R; Vivaldi A; Cioppi F; Biliotti G; Manca G; Vitti P; Serio M; Peri A
Eur J Endocrinol; 2003 May; 148(5):579-86. PubMed ID: 12720543
[TBL] [Abstract][Full Text] [Related]
12. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
Joba W; Spitzweg C; Schriever K; Heufelder AE
Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
[TBL] [Abstract][Full Text] [Related]
15. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
16. Sodium/iodide symporter mRNA expression in cold thyroid nodules.
Paschke R; Neumann S
Exp Clin Endocrinol Diabetes; 2001; 109(1):45-6. PubMed ID: 11573139
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
20. CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review.
Zarkesh M; Arab N; Abooshahab R; Heydarzadeh S; Sheikholeslami S; Nozhat Z; Salehi Jahromi M; Fanaei SA; Hedayati M
Cancer Cell Int; 2022 Oct; 22(1):310. PubMed ID: 36221112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
